Clinical Trial Update: Study of Combivir for Patients With Primary Biliary Cirrhosis [Phase 2, Phase 3]

View source ↗

Summary

Completed update for a study of Combivir (lamivudine/zidovudine) in patients with primary biliary cholangitis. The study comprises Phase 2 and Phase 3 trials.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cholangitis

Drugs mentioned

• COMBIVIR (Lamivudine and Zidovudine)

Snippet

Sponsor: University of Alberta | Conditions: Primary Biliary Cirrhosis | Phase 2, Phase 3 | Status: COMPLETED